Cargando…
miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
BACKGROUND: Accumulating evidence has revealed that aberrant microRNA (miRNA) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. Emerging evidence has demonstrated that miR-133a participates in the tumorigenesis of various...
Autores principales: | Zhou, Yang, Wang, Chunyan, Ding, Jinye, Chen, Yingying, Sun, Yaoqi, Cheng, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751326/ https://www.ncbi.nlm.nih.gov/pubmed/35012539 http://dx.doi.org/10.1186/s12935-021-02412-x |
Ejemplares similares
-
miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018) -
Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer
por: Ding, Jinye, et al.
Publicado: (2023) -
TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
por: Zhang, Ke, et al.
Publicado: (2020) -
Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma
por: Mirghasemi, Alireza, et al.
Publicado: (2015) -
MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer
por: Wang, Hui, et al.
Publicado: (2020)